| Myeloperoxidase and neurological disorder: a crosstalk K Pravalika, D Sarmah, H Kaur, M Wanve, J Saraf, K Kalia, A Borah, ... ACS chemical neuroscience 9 (3), 421-430, 2018 | 65 | 2018 |
| Trigonelline therapy confers neuroprotection by reduced glutathione mediated myeloperoxidase expression in animal model of ischemic stroke K Pravalika, D Sarmah, H Kaur, K Vats, J Saraf, M Wanve, K Kalia, ... Life sciences 216, 49-58, 2019 | 58 | 2019 |
| Getting closer to an effective intervention of ischemic stroke: the big promise of stem cell D Sarmah, H Kaur, J Saraf, K Pravalika, A Goswami, K Kalia, A Borah, ... Translational stroke research 9, 356-374, 2018 | 55 | 2018 |
| Mitochondrial dysfunction in stroke: implications of stem cell therapy D Sarmah, H Kaur, J Saraf, K Vats, K Pravalika, M Wanve, K Kalia, ... Translational stroke research 10, 121-136, 2019 | 50 | 2019 |
| Stroke management: An emerging role of nanotechnology D Sarmah, J Saraf, H Kaur, K Pravalika, RK Tekade, A Borah, K Kalia, ... Micromachines 8 (9), 262, 2017 | 50 | 2017 |
| Intra-arterial stem cell therapy modulates neuronal calcineurin and confers neuroprotection after ischemic stroke J Saraf, D Sarmah, K Vats, H Kaur, K Pravalika, M Wanve, K Kalia, ... International Journal of Neuroscience 129 (10), 1039-1044, 2019 | 29 | 2019 |
| Intra-arterial stem cell therapy diminishes inflammasome activation after ischemic stroke: a possible role of acid sensing ion channel 1a K Vats, D Sarmah, A Datta, J Saraf, H Kaur, K Pravalika, M Wanve, K Kalia, ... Journal of Molecular Neuroscience 71, 419-426, 2021 | 21 | 2021 |
| Therapeutic spectrum of interferon‐β in ischemic stroke M Wanve, H Kaur, D Sarmah, J Saraf, K Pravalika, K Vats, K Kalia, ... Journal of neuroscience research 97 (2), 116-127, 2019 | 21 | 2019 |
